Back to Results
First PageMeta Content
Pharmacology / Azacitidine / lactams / Chemistry / Decitabine / Hypomethylating agent / Nucleosides / Triazines / Medicine


DNA demethylation activity over time and safety of 3 different dose-escalation regimens of SGI-110, a novel subcutaneous (SQ) hypomethylating agent (HMA), in the treatment of relapsed/refractory patients with MDS and AML
Add to Reading List

Open Document

File Size: 627,15 KB

Share Result on Facebook
UPDATE